Table 2.
Post-bronchodilator spirometry test results in salbutamol and Fluticasone/salmeterol groups
| Variables | Salbutamol (n = 209) |
Fluticasone/Salmeterol (n = 206) |
P-value |
|---|---|---|---|
| FEV1 (L) | |||
|
Normal Overweight Obese |
3.27 ± 1.71 3.04 ± 0.97 2.89 ± 1.12 |
3.85 ± 1.75 3.41 ± 1.22 3.37 ± 1.14 |
0.051 0.148 0.013* |
| FEV1% of predicted | |||
|
Normal Overweight Obese |
95.28 ± 12.7 91.65 ± 14.7 89.93 ± 12.61 |
97.86 ± 11.9 95.32 ± 12.3 96.42 ± 11.34 |
0.221 0.116 0.002* |
| FEV1/FVC (%) | |||
|
Normal Overweight Obese |
79.23 ± 17.2 78.64 ± 12.9 74.31 ± 15.3 |
83.32 ± 16.4 82.7 ± 14.9 79.6 ± 14.2 |
0.156 0.093 0.0354* |
|
Positive Reversibility test n (%) |
17 (8.1) | 32 (15.6) | 0.018* |
FEV1: Forced expiratory volume in 1 s; FVC: Forced vital capacity